Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Machine learning-driven identification of the gene-expression signature associated with a persistent multiple organ dysfunction trajectory in critical illness.

EBioMedicine·2023

Same author

Biomarker-based risk model to predict persistent multiple organ dysfunctions after congenital heart surgery: a prospective observational cohort study.

Critical care (London, England)·2023

Same author

Identification of a pediatric acute hypoxemic respiratory failure signature in peripheral blood leukocytes at 24 hours post-ICU admission with machine learning.

Frontiers in pediatrics·2023

Same author

Biomarker-based risk model to predict persistent multiple organ dysfunctions after congenital heart surgery â€" A prospective observational cohort study.

Research square·2023

Same author

Biomarkers estimating baseline mortality risk for neonatal sepsis: nPERSEVERE: neonate-specific sepsis biomarker risk model.

Pediatric research·2022

Same author

Electrolyte derangements in critically ill children receiving balanced versus unbalanced crystalloid fluid resuscitation.

BMC nephrology·2022

Same journal

Drug Administration Patterns in Patients on Extracorporeal Membrane Oxygenation.

Journal of pediatric intensive care·2026

Same journal

Post-Intensive Care Syndrome in a Cohort of School-Aged Children and Adolescent ICU Survivors: The Importance of Follow-up in the Acute Recovery Phase.

Journal of pediatric intensive care·2025

Same journal

Retraction Note: The Effects of Quran Recitation on Sedation and Pain in Children.

Journal of pediatric intensive care·2024

Same journal

Severe Traumatic Brain Injury in French-Speaking Pediatric Intensive Care Units: Study of Practices.

Journal of pediatric intensive care·2024

Same journal

Simulation-Facilitated Education for Pediatric Critical Care Nurse Practitioners' Airway Management Skills: A 10-Year Experience.

Journal of pediatric intensive care·2024

Same journal

A Meta-analysis of the Utility of Red Cell Distribution Width as a Biomarker to Predict Outcomes in Pediatric Illness (PROSPERO CRD42020208777).

Journal of pediatric intensive care·2024

See all related articles

Search research articles

Related Experiment Video

Updated: Jan 25, 2026

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis

Published on: December 9, 2022

Sepsis Biomarkers.

Hector R Wong^1,2

¹Division of Critical Care Medicine, Cincinnati Children's Hospital Medical Center and Cincinnati Children's Research Foundation, Cincinnati, Ohio, United States.

Journal of Pediatric Intensive Care

|May 11, 2019

Summary

This summary is machine-generated.

Sepsis biomarkers aid in distinguishing infection-driven inflammation from other causes, guiding antibiotic use. They also predict patient outcomes and enable precision medicine through subgrouping.

Keywords:

biomarkers diagnostic sepsis

More Related Videos

A Data-Driven Approach to Quantifying Immune States in Sepsis

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis

Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis

Published on: June 14, 2024

Related Experiment Videos

Last Updated: Jan 25, 2026

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis

Published on: December 9, 2022

A Data-Driven Approach to Quantifying Immune States in Sepsis

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis

Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis

Published on: June 14, 2024

Area of Science:

Biochemistry
Clinical Medicine
Genomics

Background:

Sepsis biomarkers are crucial for differentiating infectious from non-infectious systemic inflammation, impacting antibiotic stewardship.
Biomarkers offer prognostic and predictive enrichment capabilities, aligning with precision medicine principles.

Purpose of the Study:

To review the applications of sepsis-related biomarkers.
To elaborate on prognostic and predictive enrichment concepts in precision medicine.
To discuss biomarker discovery and development considerations.

Main Methods:

Literature review of sepsis biomarker applications.
Conceptual elaboration on prognostic and predictive enrichment.
Discussion of biomarker discovery and development processes.

Main Results:

Sepsis biomarkers facilitate differential diagnosis of systemic inflammation.
Biomarkers identify high-risk sepsis patients for targeted interventions.
Biomarkers enable patient stratification based on biological characteristics.

Conclusions:

Sepsis biomarkers are vital for diagnosis, prognosis, and personalized treatment strategies.
Understanding biomarker applications supports the advancement of precision medicine in sepsis management.